NCT00854737View on ClinicalTrials.gov

Cytidine and Omega-3 Fatty Acids in Bipolar Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

July 31, 2010

Conditions
Bipolar Disorder
Interventions
DIETARY_SUPPLEMENT

cytidine

cytidine (2g po daily for 4 months)

DIETARY_SUPPLEMENT

omega-3 fatty acids

omega-3 fatty acids (4g po daily for 4 months)

DRUG

placebo

sugar pill

Trial Locations (2)

02478

McLean Hospital, Belmont

07753

Jersey Shore University Medical Center, Neptune City

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Mclean Hospital

OTHER

NCT00854737 - Cytidine and Omega-3 Fatty Acids in Bipolar Disorder | Biotech Hunter | Biotech Hunter